Lanza R. (ed.), Weissman I. (ed.), Thomson J. (ed.) — Handbook of Stem Cells (vol. 1) Embryonic Stem Cells :: Электронная библиотека попечительского совета мехмата МГУ

Главная Ex Libris Книги Журналы Статьи Серии Каталог Wanted Загрузка ХудЛит Справка Поиск по индексам Поиск Форум

Авторизация

Поиск по указателям

Lanza R. (ed.), Weissman I. (ed.), Thomson J. (ed.) — Handbook of Stem Cells (vol. 1) Embryonic Stem Cells

Обсудите книгу на научном форуме

Нашли опечатку?
Выделите ее мышкой и нажмите Ctrl+Enter

Название: Handbook of Stem Cells (vol. 1) Embryonic Stem Cells

Авторы: Lanza R. (ed.), Weissman I. (ed.), Thomson J. (ed.)

Аннотация:

The Handbook of Stem Cells, edited by Robert Lanza and colleagues, is an ambitious new text that achieves extraordinary completeness and inclusiveness...the editors have succeeded in putting together a reference that is broad enough in scope, but sufficiently detailed and rigorous, to be of real interest to both new and seasoned investigators in the field.

Язык:

Рубрика: Биология/

Статус предметного указателя: Готов указатель с номерами страниц

ed2k: ed2k stats

Год издания: 2004

Количество страниц: 843

Добавлена в каталог: 16.04.2007

Операции: Положить на полку | Скопировать ссылку для форума | Скопировать ID

Предметный указатель

Null allele mutations      1: 599—600
Obesity      1: 329 1: 2:
Oct 4 transcription factor      2: 37
Oct 4 transcription factor as marker of pluripotency      1: 33—39 1: 1: 1:
Oct 4 transcription factor as repressor of trophoblast lineage      1: 198—200
Oct 4 transcription factor in ES cell self-renewal      1: 45 1: 1: 1: 1: 1:
Oct 4 transcription factor in preimplantation development      1: 148—149
Oct 4 transcription factor in situ hybridization probe      1: 648—649
Oct 4 transcription factor in somatic cell nuclear transfer clones      1: 625
Oct 4 transcription factor, expression      1: 34—36 1: 1:
Oct 4 transcription factor, function      1: 34 1:
Oct 4 transcription factor, genomic structure      1: 35f
Oct 4 transcription factor, human ES cell expression      1: 408
Oct 4 transcription factor, human ES cell knockin      1: 553—554 1:
Oct 4 transcription factor, POU domain      1: 33
Oct 4 transcription factor, reprogramming somatic cell nuclei with pluripotent cell cytoplasm      1: 3—4
Oct 4 transcription factor, target genes      1: 36 1:
Odontoblasts      2: 279 2:
Odontoblasts, tooth development      2: 280—281
Olfactory epithelium      2: 233—240
Olfactory progenitor cells      2: 238—239 2:
Olig2 transcription factor      2: 197
Oligodendrocytes      1: 238 1:
Oligodendrocytes, lineage development      1: 573
Oligodendrocytes, spine development      1: 704
Oligonucleotide microarrays      2: 643—645 2:
Oligonucleotides, single-stranded DNA      2: 793
Oligonucleotides, triplex forming      2: 793
Oncostatin M (OSM)      1: 28
Oncostatin M (OSM) in gp30/gp130 dimerization      1: 28—29
Oocytes, genomic reprogramming in      1: 659
Oocytes, maternal inheritance      1: 659
Oogenesis      1: 187
Oogenesis, primordial germ cells in      1: 189—190
OP9 stromal cells      1: 317—318 1:
OPN      1: 37
Optic nerve      2: 704
Optic tectum      2: 705
Optic vesicle      1: 253 1: 2:
Oral mucosa      2: 8 2:
Organelle fusion      2: 153
Osteoarthritis      2: 773
Osteoblasts in bone marrow formation      1: 299
Osteoblasts in hematopoietic stem cell niches      2: 64—65
Osteoblasts, adipogenesis and      1: 332—333
Osteoblasts, differentiation      1: 289—290
Osteoblasts, function      1: 285
Osteoblasts, lineage      2: 299—300 2:
Osteoblasts, osteogenesis      2: 431—432
Osteoblasts, statin effects      1: 332
Osteoclasts in bone marrow formation      1: 296—297 1:
Osteoclasts, cell fusion      1: 295 2:
Osteoclasts, culture system      1: 297—301 1:
Osteoclasts, defined      1: 295
Osteoclasts, development      1: 295—296
Osteoclasts, function      1: 295
Osteoclasts, localization      1: 295
Osteoclasts, phylogenetic comparison      1: 296 1:
Osteoclasts, precursor cells      1: 295—296 1: 1:
Osteocytes, amniotic fluid progenitor cell-derived      2: 178
Osteocytes, lineage      2: 299—300 2:
Osteogenesis imperfecta      2: 773 2:
Osteoporosis      1: 295 1: 2:
Osteoporosis, statin therapy      1: 332
Osteoprotegerin      1: 295 1:
Osx transcription factor      1: 290
Otic placode cells      1: 257—260
Oval cells      2: 485—486 2:
Oval cells, activation      2: 500—501
Oval cells, amplification      2: 507
Oval cells, amplification, termination of proliferation      2: 508
Oval cells, differentiation      2: 507
Oval cells, location      2: 499
Oval cells, precursors      2: 499
Oval cells, stem-like properties of      2: 502—503
Oval cells, transcription regulation      2: 504 2:
Ovarian steroids      2: 221
Ovaries, Drosophila germ line stem cell niches      2: 60 2: 2:
Ovaries, embryonic development      1: 346—347 1: 1:
Oxygen-regulated gene expression      1: 91—92
p16      2: 77
p18      2: 77
p21      2: 73 2: 2:
p27      2: 73 2: 2:
p300      2: 108 2:
p53 in ES cell cycle regulation      1: 57—58
p53 in telomere function      2: 134
p53, genetic pathway analysis      1: 585
p55      2: 105—106
p55 in cell cycle regulation      2: 119—120
p63      2: 251 2:
Palindromic Oct-factor recognition element      1: 37
Pancreas development in Xenopus      1: 485—486
Pancreas transplant      1: 723
Pancreatic $\beta$ -cells      1: 723—727 2:
Pancreatic $\beta$ -cells, bone marrow-derived      2: 517
Pancreatic $\beta$ -cells, differentiation      1: 723—724
Pancreatic $\beta$ -cells, ES cell-derived      1: 506
Pancreatic $\beta$ -cells, experimental models      1: 724—725
Pancreatic $\beta$ -cells, human studies      1: 725
Pancreatic $\beta$ -cells, immunogenicity      1: 727
Pancreatic $\beta$ -cells, in vitro cultivation      2: 518
Pancreatic $\beta$ -cells, interaction with non-P-cells      1: 726—727
Pancreatic $\beta$ -cells, neogenesis      2: 732—733
Pancreatic $\beta$ -cells, obesity and      2: 732
Pancreatic $\beta$ -cells, postnatal development      2: 515
Pancreatic $\beta$ -cells, precursor cells      2: 733 2:
Pancreatic $\beta$ -cells, progenitors      2: 515
Pancreatic $\beta$ -cells, research needs      1: 725
Pancreatic $\beta$ -cells, self-renewal      2: 732
Pancreatic $\beta$ -cells, therapeutic rationale      1: 723 2:
Pancreatic acinar cells      2: 733—734
Pancreatic acinar cells, adult      2: 516
Pancreatic AR42J cells      2: 733—734
Pancreatic AR42J cells, hepatocytes formed from      2: 139—140
Pancreatic cells from liver cells      2: 140—141 2:
Pancreatic cells, embryonic development      2: 513—515
Pancreatic cells, progenitor cells      2: 487—4188
Pancreatic cells, types      2: 513 (see also “Specific cell type”)
Pancreatic duct cells, adult      2: 515—516
Pancreatic duct cells, islet cell neogenesis      2: 732—733
Pancreatic duct cells, self-renewal      2: 731
Pancreatic heterotopia      2: 140—141
Pancreatic progenitor cells      2: 518—519
Pancreatic progenitor cells in adult pancreas      2: 515—517
Pancreatic progenitor cells in organogenesis      2: 514
Pancreatic progenitor cells, exogenous sources      2: 517—518
Pancreatic stem cells      2: 513—519
Paneth cells      2: 7 2: 2:
Paraclones      2: 246—247 2:
Parathyroid development, cell specification for      1: 393
Parathyroid development, endoderm      1: 379
Parathyroid development, evolutionary considerations      1: 397—398
Parathyroid development, intercellular signaling in      1: 394—395
Parathyroid development, model      1: 391
Parathyroid development, molecular control      1: 392f
Parathyroid development, pharyngeal pouch and      1: 391—393
Parathyroid development, primordia      1: 395—397
Parathyroid development, separation and migration of rudiments      1: 397
Parathyroid development, terminal differentiation      1: 399
Parathyroid development, transcription regulation      1: 393—394
Parathyroid hormone-related peptide      1: 288 1:
Parkinson’s Disease      1: 245 1: 2: 2:
Parthenogenesis      1: 669—670
Patient advocacy      1: 805—806
Pax transcription factors in B cell development      2: 97—98
Pax transcription factors in embryonic kidney development      1: 338—340 1:
Pax transcription factors in gastrointestinal development      1: 372—373
Pax transcription factors in thymus and parathyroid development      1: 394 1:
Pax transcription factors in thymus development      2: 557

Pax transcription factors in transdifferentiation      2: 150
Pax transcription factors, B cell deficiency      2: 87
Pax transcription factors, genetic pathway studies      1: 584—585
Pax transcription factors, myogenic stem cell expression      2: 572 2:
PCAF gene      2: 109
Pdxl gene      2: 150 2:
Pelizaeus — Merzbacher syndrome      1: 246
Peptic-chief cells      2: 522
Pericytes      2: 418—419 2:
Periodontal stem cells      2: 284—285
Periodontium      2: 279
Peripheral blood stem cell transplant      2: 751—754
Peripheral blood stem cell transplant, government regulation of stem cell products      2: 805
Peripheral nervous system development      2: 225—230
Peripheral nervous system development, stem cell populations      2: 229—230
Peritubular myoid cells      1: 352
Pern      1: 49
Peroxisome proliferative-activated receptor gamma in differentiation of ES cells in adipocytes      1: 329—331 1:
Peroxisome proliferative-activated receptor gamma, statin effects      1: 332
Pharyngeal pouch      1: 391—393
Phenotype differences in ES cell nuclear transfer clones      1: 626—628
Phenotype differences in germ line transmission      1: 589
Phenotype differences in germ line transmission, epigenetic mechanisms      1: 593—594
Phenotype differences in germ line transmission, exon interruption      1: 593
Phenotype differences in germ line transmission, hitchhiker effect      1: 592—593
Phenotype differences in germ line transmission, intron interruption      1: 593
Phenotype differences in germ line transmission, strain variation as cause of      1: 589—592
Phenotype differences in germ line transmission, strategies for controlling      1: 594—595
Phenotype differences in somatic cell nuclear transfer      1: 624—625
Phenotype differences, changes in adult stem cells      2: 139—143
Phenotype differences, clonal assays      2: 667
Phenotype differences, slide population cells      2: 24 2:
Pheremone detection      2: 233
Photoreceptor cells      1: 253 1:
PI3K in cyclin D1 regulation      1: 56
PI3K in ES cell cycle regulation      1: 56
Pierce, Barry      1: 15
Pim—1      1: 58
Placental development      1: 95—96
Placental development, genetic mutants in      1: 194
Placental development, trophoblast development      1: 193—196 1:
Placental growth factor, in proangiogenic stem cell recruitment      2: 377 2:
Plant stem cell systems, cell fate determinations      2: 631
Plant stem cell systems, characteristics      2: 631
Plant stem cell systems, maintenance      2: 635—639
Plant stem cell systems, organization      2: 631 2:
Plant stem cell systems, shoot apical meristem      2: 631 2: 2:
Plant stem cell systems, stem cell reservoir      2: 632—635
Plasticity of somatic stem cells      2: 22 (see also “Transdifferentiation”)
Plasticity, conceptualization in stem cell research      2: 2—3 2:
Plasticity, evidence of transdifferentiation      2: 13—15
Plasticity, evidence of transdifferentiation, possible explanations for      2: 15—16 2:
Plasticity, plant stem cell systems      2: 631
Plasticity, skeletal development      2: 420
Platelet-derived growth factor      2: 457 2:
Platelet-derived growth factor in embryonic kidney development      1: 342
Platelet-derived growth factor in ES cell culturing      1: 532
Platelet-derived growth factor in gastrointestinal development      1: 374 1:
Platelet-derived growth factor in gonad development      1: 349 1: 1:
Platelet-derived growth factor, gastrointestinal cell regulation      2: 522
Pluripotency in hybrid cells      1: 112—113
Pluripotency of EC cells      1: 27
Pluripotency of EG cells      1: 27—28
Pluripotency of ES/ESL cells      1: 20 1: 1: 1:
Pluripotency of late stage ES cells      1: 424
Pluripotency, amniotic fluid-derived cells      2: 175—179
Pluripotency, assessment of      1: 20
Pluripotency, cellular models      1: 27—28
Pluripotency, defined      1: 16 1: 2: 2:
Pluripotency, epiblast      1: 129
Pluripotency, evolutionary value      1: 138
Pluripotency, gene expression in      1: 33 1:
Pluripotency, genetic model of molecular control of      1: 38—39 1:
Pluripotency, leukemia inhibitory factor in      1: 28
Pluripotency, loss of, in differentiation      1: 640
Pluripotency, measurement after transplantation      1: 640—647
Pluripotency, mouse embryos      1: 639—652
Pluripotency, multipotent adult progenitor cells      2: 294 2:
Pluripotency, OCT4 in      1: 33—39
Pluripotency, stem cell self-renewal and      1: 45
Pluripotency, Xenopus animal cap cells      1: 483
Podacalyxin      1: 585
Podocyte      1: 341
Polarity, epiblast      1: 136—137
Polarity, specification during preimplantation      1: 144—146
Polio      1: 701 2:
Polycomb group proteins in genomic reprogramming of oocyte      1: 659
Polycomb group proteins, silencing      1: 67 1: 1: 1:
Polymerase chain reaction      2: 654
Porphyria      2: 681
Position-effect variegation      1: 67 1:
Potency assays      2: 806 2:
Potential stem cells      2: 3 2:
POU factors      1: 33 1:
Pregnancy, cancer risk in      2: 275
Primitive ectoderm      1: 45 1:
Primitive endoderm      see “Endoderm primitive”
Primitive streak      1: 133—134 1: 1:
Primitive streak, fate map      1: 275 1:
Primitive streak, formation and development      1: 335
Primitive streak, mesoderm development      1: 273—275
Primitive streak, node      1: 273 1: 1:
Primitive streak, origin      1: 273
Primordial germ cells      1: 11f 1:
Primordial germ cells in genital ridge      1: 189—190
Primordial germ cells in gonad development      1: 352—353
Primordial germ cells, cell markers      1: 451
Primordial germ cells, defined      1: 187
Primordial germ cells, demethylation      1: 68
Primordial germ cells, early research      1: 187—188
Primordial germ cells, EG cell derivation      1: 190—191 1: 1:
Primordial germ cells, epigenetic reprogramming in      1: 658—659
Primordial germ cells, gene expression      1: 188—189
Primordial germ cells, growth medium      1: 465
Primordial germ cells, identification      1: 187—188
Primordial germ cells, in vitro proliferation      1: 451—452 1:
Primordial germ cells, isolation      1: 451—452
Primordial germ cells, lineage determination      1: 188
Primordial germ cells, methylation      1: 190
Primordial germ cells, migration      1: 189
Primordial germ cells, origins      1: 277
Primordial germ cells, pluripotency      1: 146
Primordial germ cells, specification      1: 657—658
Primordial germ cells, stem cells derived from      1: 658
Primordial germ cells, sternness      1: 187
Processed lipoaspirate cells      2: 425—440
Processed lipoaspirate cells in adipogenesis      2: 429—431 2:
Processed lipoaspirate cells in chondrogenesis      2: 434—436 2:
Processed lipoaspirate cells in myogenesis      2: 436—439
Processed lipoaspirate cells in osteogenesis      2: 431—4134 2:
Processed lipoaspirate cells, cell surface markers      2: 427—429 2:
Processed lipoaspirate cells, clinical potential      2: 439—440
Processed lipoaspirate cells, isolation and characterization      2: 426—429
Processed lipoaspirate cells, mesenchymal stem cells and      2: 426f 2:
Processed lipoaspirate cells, multipotent phenotype      2: 438—439
Processed lipoaspirate cells, neurogenic differentiation      2: 437—438
Processed lipoaspirate cells, potency and plasticity      2: 425 2: 2:
Processed lipoaspirate cells, therapeutic applications      2: 439—440
Processed lipoaspirate cells, totipotency      2: 438
Progenitor cell, defined      2: 513
Progenitor cell-line-microarray      1: 582 1: 1:
Progesterone      1: 151
Proneural genes      2: 193—199
Propidium iodide      2: 330
Prostaglandins in Sertoli cell differentiation      1: 349
Proteases      2: 599
Proteases in proangiogenic stem cell recruitment      2: 378
Proteomic analysis      2: 38
Proximal enhancer      1: 34—36
Proximal epiblast enhancer      1: 136

1 2 3 4 5 6 7 8 9 10 11 12

О проекте